Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarker, Molecular, and Technologic Advances in Urologic Pathology, Oncology, and Imaging.

Archives of pathology & laboratory medicine - 1 Apr 2017

Ellis Carla L, Harik Lara R, Cohen Cynthia, Osunkoya Adeboye O

Abstract excerpt

Urologic pathology is evolving rapidly. Emerging trends include the expanded diagnostic utility of biomarkers and molecular testing, as well as adapting to the plethora of technical advances occurring in genitourinary oncology, surgical practice, and imaging. We illustrate those trends by highlighting our approach to the diagnostic workup of a few selected disease entities that pathologists may encounter,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Chromosome Aberrations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnosis, Differential

Share to Genetic Predisposition to Disease

Share to Immunohistochemistry

Share to Pathology, Molecular

Share to Sensitivity and Specificity

Share to Urologic Neoplasms

Source

Identifiers

PMID: 28157406
DOI: 10.5858/arpa.2016-0263-SA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarker, Molecular, and Technologic Advances in Urologic Pathology, Oncology, and Imaging.PMID 28157406Read ↗

Select updates in the pathology of kidney, testis, and penile cancer for 2026: Including FLCN-mutated (kidney) tumors, paratesticular mesothelial tumors, and TP53/HPV status in penile squamous cell carcinoma.Semantic proximity Read ↗

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.Semantic proximity Read ↗

Biomarkers in renal cancer.Semantic proximity Read ↗

Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer.Semantic proximity Read ↗

Beta Defensin-1, Parvalbumin, and VimentinSemantic proximity Read ↗

Advances in Urinary Biomarkers for the Early Detection of Urological Cancers: From Proteins and Epigenetics to Gene Mutations.Semantic proximity Read ↗

A sensitive and specific non-invasive urine biomarker panel for prostate cancer detectionSemantic proximity Read ↗

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors.Semantic proximity Read ↗

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers V: Recommendations on the Use of Immunohistochemical and Molecular Biomarkers in Penile Cancer.Semantic proximity Read ↗

Temporal changes in the pathologic assessment of prostate cancer.Semantic proximity Read ↗

The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies.Semantic proximity Read ↗

Genotype Phenotype Correlation of Renal Tumors in the Cancer Genome Atlas DatabaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.